Diagnosis of Histamine Overload
The diagnosis of histamine overload requires documenting recurrent episodes affecting at least 2 organ systems simultaneously (cardiovascular, dermatologic, respiratory, or gastrointestinal), with acute elevation of mast cell mediators during symptomatic episodes, and clinical response to histamine-blocking therapy or mast cell stabilizers. 1
Clinical Diagnostic Criteria
The diagnosis should be considered when patients present with episodic symptoms involving at least 2 of the following 4 organ systems concurrently 1:
- Cardiovascular: Hypotension, tachycardia, syncope or near-syncope 1
- Dermatologic: Urticaria, pruritus, flushing, angioedema (particularly eyelids, lips, tongue) 1
- Respiratory: Wheezing, shortness of breath, inspiratory stridor 1
- Gastrointestinal: Crampy abdominal pain, diarrhea, nausea, vomiting 1
Critical distinction: Persistent or chronic symptoms (such as chronic urticaria or poorly controlled asthma) should direct you toward alternative diagnoses, not histamine overload. 1 The hallmark is episodic, recurrent attacks with symptom-free intervals. 1
Laboratory Testing Algorithm
Acute Episode Testing (Priority)
During an active symptomatic episode, obtain the following measurements 1:
Serum tryptase: Collect between 1-2 hours after symptom onset (peaks at 60-90 minutes, persists up to 6 hours). 1 An acute elevation >baseline × 1.2 + 2 ng/mL supports mast cell activation. 1
Plasma histamine: Only useful if collected within 10-60 minutes of symptom onset (peaks at 5-10 minutes, normalizes by 60 minutes). 1 This is rarely practical in clinical settings. 1
24-hour urine collection for N-methylhistamine or histamine metabolites: Remains elevated for up to 24 hours after an episode, making it the most practical test for retrospective diagnosis when acute markers are missed. 1, 2
Baseline Testing
Between episodes, measure 1:
- Baseline serum tryptase: A persistently elevated baseline tryptase (>20 ng/mL in 75% of cases) suggests systemic mastocytosis rather than isolated histamine overload. 1 A ratio of total tryptase to β-tryptase ≥20 indicates systemic mastocytosis, while a ratio ≤10 suggests anaphylaxis without mastocytosis. 1
The diagnosis requires documenting mediator elevation on at least 2 separate occasions during symptomatic episodes. 1
Differential Diagnosis Exclusions
Before confirming histamine overload, systematically exclude 1:
- Systemic mastocytosis: Baseline tryptase >20 ng/mL, bone marrow biopsy showing mast cell infiltration 1
- Hereditary α-tryptasemia: Baseline tryptase >8 ng/mL without mastocytosis 1
- Pheochromocytoma: Plasma-free metanephrine, urinary vanillylmandelic acid 1
- Carcinoid syndrome: Serum serotonin, urinary 5-hydroxyindoleacetic acid 1
- Vasoactive intestinal peptide-secreting tumors: VIP panel including pancreastatin, substance P 1
- Scombroid fish poisoning: History of spoiled fish ingestion (tuna, mackerel, mahi-mahi), multiple individuals affected, normal tryptase 1, 3
- IgE-mediated food allergy: Specific IgE testing (skin or blood) if suspected 1
Therapeutic Confirmation
A positive response to targeted therapy is required to confirm the diagnosis 1:
If only urinary histamine metabolites are elevated: H1 and H2 antihistamine therapy should improve symptoms. 1 Start with cetirizine 10 mg daily or loratadine 10 mg daily, plus famotidine 20 mg twice daily. 4
If prostaglandin metabolites (11β-PGF2α) are elevated: Aspirin therapy (with appropriate precautions) should reduce symptoms. 1
Mast cell stabilizers (cromolyn sodium) may be beneficial if antihistamines alone are insufficient. 1
Common Diagnostic Pitfalls
Mistaking chronic symptoms for episodic disease: Histamine overload presents with discrete attacks, not continuous symptoms. 1
Testing at the wrong time: Plasma histamine is useless >1 hour after symptom onset; serum tryptase is useless >6 hours after onset. 1 Use 24-hour urine collection for late presentations. 2
Confusing histamine intolerance with histamine overload: Histamine intolerance (reduced diamine oxidase activity) causes symptoms after normal dietary histamine intake and presents with more chronic, food-related symptoms. 5, 6, 7 This is a distinct entity requiring dietary histamine restriction and DAO supplementation. 5, 8
Missing underlying systemic mastocytosis: Always check baseline tryptase; if >20 ng/mL, pursue bone marrow evaluation. 1
Single mediator measurement: The diagnosis requires at least 2 documented episodes with elevated mediators. 1
Assessment of Associated Conditions
Evaluate for comorbid conditions that frequently coexist 1:
- Postural orthostatic tachycardia syndrome (POTS): Common in patients with hypermobile Ehlers-Danlos syndrome and mast cell activation 1
- Gastrointestinal dysmotility: Consider gastric emptying studies if upper GI symptoms predominate 1
- Pelvic floor dysfunction: Anorectal manometry if lower GI symptoms present 1